CYP1A1 protein activity is associated with allelic variation in pterygium tissues and cells

Molecular Vision

Volumn 18, Issue , 2012, Pages 1937-1943

  Peng, Mei Ling ^a,b   Tsai, Yi Yu ^c   Chiang, Chun Chi ^c   Huang, Ying Che ^a   Chou, Ming Chih ^a   Yeh, Kun Tu ^d   Lee, Huei ^a,e   Cheng, Ya Wen ^a,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; CYTOCHROME P450 1A1; MONOCLONAL ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CYTOCHROME P450 1A1 GENE; DNA ADDUCT; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PTERYGIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PRIMARY CELL CULTURE; PTERYGIUM; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TAIWAN;

EID: 84865830195     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingula, pterygia, and limbal tumors. Curr Eye Res 1997; 16:1179-92. [PMID: 9426949]
2. Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997; 123:404-5. [PMID: 9063255]
3. Dushku N, Hatcher SLS, Albert DM. P53 expression and relation to human papillomavirus infection in pinguecula, pterygia, and limbal tumors. Arch Ophthalmol 1999; 117:1593-9. [PMID: 10604662]
4. Onur C, Orhan D, Orhan M, Dizbay Sak S, Tulunay O, Irkeç M. Expression of p53 protein in pterygia. Eur J Ophthalmol 1998; 8:157-61. [PMID: 9793769]
5. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84:212-6. [PMID: 10655200]
6. Chowers I, Pe'er J, Zamir E, Livni N, Ilsar M, Frucht-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001; 108:985-8. [PMID: 11320032]
7. Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye (Lond) 2002; 16:619-21. [PMID: 12194078]
8. Shimada T, Yun CH, Yamasaki H, Gautier JC, Beaune PH, Guengerich FP. Characterization of human lung microsomal cytochrome P450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 1992; 41:856-64. [PMID: 1588920]
9. London SJ, Daly AK, Leathart JBS, Navidi WC, Idle JR. Lung cancer risk in relation to the CYP2C9*1/CYP2CP*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 1996; 6:527-33. [PMID: 9014202]
10. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9:3-28. [PMID: 10667460]
11. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990; 263:131-3. [PMID: 1691986]
12. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 1992; 83:866-70. [PMID: 1399823]
13. Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, Wong YK, Chi LY, Liu TY. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med 2002; 31:505-11. [PMID: 12269988]
14. Tung JN, Wu HH, Chiang CC, Tsai YY, Chou MC, Lee H, Cheng YW. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium. Mol Vis 2010; 16:623-9. [PMID: 20700368]
15. Young CH, Lo YL, Tsai YY, Shih TS, Lee H, Cheng YW. CYP1A1 gene polymorphisms as a risk factor for pterygium. Mol Vis 2010; 16:1054-8. [PMID: 20596254]
16. Gaillard C, Strauss F. Ethanol precipitation of DNA with linear polyacrylamide as carrier. Nucleic Acids Res 1990; 18:378. [PMID: 2326177]
17. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 1991; 110:407-11. [PMID: 1722803]
18. Cheng YW, Chen CY, Lin P, Huang KH, Lin TS, Wu MH, Lee H. DNA adduct level in lung tissue may act as a risk biomarker of lung cancer. Eur J Cancer 2000; 36:1381-8. [PMID: 10899651]
19. Cheng YW, Hsieh LL, Lin P, Chen CP, Chen CY, Lin TS, Su JM, Lee H. Gender difference in DNA adduct levels among non-smoking lung cancer patients. Environ Mol Mutagen 2001; 37:304-10. [PMID: 11424180]
20. TsaiYYChiangCCYehKTLeeHChengYWEffect of TIMP-1 and MMP in pterygium invasion. Invest Ophthalmol Vis Sci20105134627. [PubMed: 20207965]
21. Mumford JL, Williams K, Wilcosky TC, Everson EB, Young TL, Santella RM. A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues. Mutat Res 1996; 359:171-7. [PMID: 8618549]
22. Santella RM, Weston A, Perera FP, Trivers GT, Harris CC, Young TL, Nguyen D, Lee BM, Poirier MC. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis 1988; 9:1265-9. [PMID: 3133129]
23. Uppstad H, Osnes GH, Cole KJ, Charchian R, Matilla JR, Sano A, Klepetko W. Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells. Lung Cancer 2011; 71:264-70. [PMID: 20951464]
24. McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 1990; 82:1333-9. [PMID: 2380990]
25. Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999; 59:3317-20. [PMID: 10416585]
26. Mollerup S, Berge G, Bara R, Skaug V, Hewer A, Phillips DH, Stangeland L, Haugen A. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer 2006; 119:741-4. [PMID: 16557573]